...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma
【24h】

Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma

机译:通过皮肤T细胞淋巴瘤循环肿瘤克隆的皮肤殖民

获取原文
获取原文并翻译 | 示例

摘要

Mycosis fungoides (MF) is a mature T-cell lymphoma currently thought to develop primarily in the skin by a clonal expansion of a transformed, resident memory T cell. However, this concept does not explain the key characteristics of MF, such as the debut with multiple, widespread skin lesions or inability of skin-directed therapies to provide cure. The testable inference of the mature T-cell theory is the clonality of MF with respect to all rearranged T-cell receptor (TCR) genes. Here, we used a whole-exome sequencing approach to detect and quantify TCR-alpha, beta, and gamma clonotypes in tumor cell clusters microdissected from MF lesions. This method allowed us to calculate the tumor cell fraction of the sample and therefore an unequivocal identification of the TCR clonotypes as neoplastic. Analysis of TCR sequences from 29 patients with MF stage I to IV proved the existence of multiple T-cell clones within the tumor cell fraction, with a considerable variation between patients and between lesions from the same patient (median, 11 clones; range, 2-80 clones/sample). We have also detected multiple neoplastic clones in the peripheral blood in all examined patients. Based on these findings, we propose that circulating neoplastic T-cell clones continuously replenish the lesions of MF, thus increasing their heterogeneity by a mechanism analogous to the consecutive tumor seeding. We hypothesize that circulating neoplastic clones might be a promising target for therapy and could be exploited as a potential biomarker in MF.
机译:蕈菌菌诱导(MF)是一种成熟的T细胞淋巴瘤,目前被认为是通过转化的常规记忆T细胞的克隆膨胀来主要在皮肤中发育。然而,这种概念并未解释MF的关键特性,例如具有多种,广泛的皮肤病变或无能为力的皮肤疗法的首次亮相以提供治疗。成熟T细胞理论的可测试推断是MF关于所有重排细胞受体(TCR)基因的克隆性。在这里,我们使用了全面的序列测序方法来检测和定量来自MF病变的肿瘤细胞簇中的TCR-α,β和γClOnotypes。该方法使我们能够计算样品的肿瘤细胞分数,从而造成TCR Clonotypes作为肿瘤的肿瘤鉴定。分析来自29例MF阶段I至IV患者的TCR序列证明了肿瘤细胞级分中多个T细胞克隆的存在,患者与来自同一患者的病变之间的相当大的变异(中位数,11个克隆;范围,2 -80克隆/样品)。我们还发现了所有检查患者的外周血中的多个肿瘤克隆。基于这些发现,我们提出循环肿瘤T细胞克隆连续补充MF的病变,从而通过类似于连续肿瘤播种的机制增加它们的异质性。我们假设循环肿瘤克隆可能是治疗的有希望的靶标,并且可以作为MF中的潜在生物标志物被开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号